|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/03 | |
| A61K 47/00 | |||
| A61K 9/00 | |||
| A61P 37/00 | |||
| A61K 47/10 | |||
| A61K 9/20 |
| (11) | Number of the document | 3119413 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15764661.3 |
| Date of filing the European patent application | 2015-03-16 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2015/050275 |
| Date | 2015-03-16 |
| (87) | Number | WO 2015/140790 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 201461953945 P | 2014-03-17 | US |
| (72) |
SELA, Yoram, IL
MAROM, Ehud, IL
BLEICH KIMELMAN, Nadav, IL
|
| (73) |
Mapi Pharma Limited,
16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona,
IL
|
| (54) | SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE |
| SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE |